Results 181 to 190 of about 60,557 (265)
Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection. [PDF]
Pickles RJ, Chen G, Randell SH.
europepmc +1 more source
Respiratory Syncytial Virus Induces B Cell Activating Factor (BAFF) in Airway Epithelium: A Potential Avenue for Mucosal Vaccine Development. [PDF]
Alturaiki W, Flanagan B.
europepmc +1 more source
Emerging Risk: Intranasal Tin Exacerbates Allergic Rhinitis in Humans and Mice
Allergy, EarlyView.
Delgama A. S. M. Nishadhi +9 more
wiley +1 more source
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis
ABSTRACT Allergic rhinitis (AR) is a common, persistent nasal disorder that poses significant public health challenges worldwide. Current treatment options frequently fail to achieve adequate symptom control in a substantial subset of patients. Over the past two decades, biologic therapies that target type 2 inflammatory pathways have been used to ...
Yuan Zhang +37 more
wiley +1 more source
Human airway epithelium controls Pseudomonas aeruginosa infection via inducible nitric oxide synthase. [PDF]
Grubwieser P +13 more
europepmc +1 more source
IL‐33 induces inflammatory gene signatures in eosinophils, characterised by the upregulation of cell surface markers, inflammatory mediators and regulatory factors, all of which were also observed in nasal polyp‐derived eosinophils. Ox‐LDL and complement fragments (C3a and C5a) promote eosinophil adhesion and survival.
Emiko Matsuyama +16 more
wiley +1 more source
Background and Purpose Interleukin (IL)‐13 is implicated in airway hyperreactivity (AHR), a key feature of asthma. We explored the potential anti‐AHR activity of selected specialised pro‐resolving mediators (SPMs) in IL‐13‐induced AHR models, using human bronchial smooth muscle cells (BSMCs) and human isolated bronchi.
Willem Abma +9 more
wiley +1 more source
A map of signaling responses in the human airway epithelium. [PDF]
McCauley KB +4 more
europepmc +1 more source
Abstract Background and Purpose Spleen tyrosine kinase (SYK) has broad biological functions in inflammation and immunity. The orally administered SYK inhibitor BI 894416 was investigated in a single‐rising‐dose Phase I study in healthy volunteers and in a combined single‐ and multiple‐rising‐dose Phase Ib study in patients with mild asthma ...
Saskia Carstensen‐Aurèche +8 more
wiley +1 more source

